C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/16 (2006.01) C12N 9/22 (2006.01) C12N 15/10 (2006.01) C12N 15/11 (2006.01) C12N 15/62 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2108134
2108134 9222642 PCTABS00018 The present invention is directed to fusion proteins comprising ligand-protein hybrids. These hybrids can cleave any predetermined site within a DNA or RNA molecule, or hydrolyze a defined number of nucleotides from the DNA or RNA termini. In particular, the fusion proteins of the invention are composed of a ligand-exonuclease, or a ligand-endonuclease. Methods for using these fusion proteins are also encompassed in the present invention. Specifically, the present invention is directed to a Staphylococcal fusion protein.
Chang Yie-Hwa
Smith John A.
Gowling Lafleur Henderson Llp
The General Hospital Corporation
LandOfFree
Universal site-specific nucleases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Universal site-specific nucleases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Universal site-specific nucleases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1865702